215 related articles for article (PubMed ID: 27839749)
21. Use of omalizumab for management of idiopathic anaphylaxis: A systematic review and retrospective case series.
Kaminsky LW; Aukstuolis K; Petroni DH; Al-Shaikhly T
Ann Allergy Asthma Immunol; 2021 Oct; 127(4):481-487. PubMed ID: 34175498
[TBL] [Abstract][Full Text] [Related]
22. Food-dependent exercise-induced anaphylaxis to soybean.
Izadi N; Rabinovitch N
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):303-304. PubMed ID: 29802905
[No Abstract] [Full Text] [Related]
23. Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab.
Geller M
Ann Allergy Asthma Immunol; 2016 Jan; 116(1):81-2. PubMed ID: 26602491
[No Abstract] [Full Text] [Related]
24. Omalizumab, a savior in long term prevention of idiopathic anaphylaxis with urticaria: A case series.
Singh GK
Dermatol Ther; 2021 Nov; 34(6):e15165. PubMed ID: 34676646
[No Abstract] [Full Text] [Related]
25. Overcoming severe adverse reactions to venom immunotherapy using anti-IgE antibodies in combination with a high maintenance dose.
Stretz E; Oppel EM; Räwer HC; Chatelain R; Mastnik S; Przybilla B; Ruëff F
Clin Exp Allergy; 2017 Dec; 47(12):1631-1639. PubMed ID: 28802075
[TBL] [Abstract][Full Text] [Related]
26. Occupational allergic respiratory disease (rinoconjunctivitis and asthma) in a cheese factory worker.
Gómez Torrijos E; García Rodriguez C; Veleiro Pérez B; Bartolomé B; Prado Barragan M; Garcia Rodriguez R
J Allergy Clin Immunol Pract; 2018; 6(4):1416-1417. PubMed ID: 29342450
[No Abstract] [Full Text] [Related]
27. Fatal asthma after omalizumab and controller therapy discontinuation.
Lombardi C; Cottini M; Passalacqua G
Eur Ann Allergy Clin Immunol; 2018 Jul; 50(5):235-236. PubMed ID: 30039694
[No Abstract] [Full Text] [Related]
28. Twelve-year follow-up of omalizumab therapy for anaphylaxis in 2 patients with systemic mastocytosis.
Constantine GM; Bressler PB; Petroni D; Metcalfe DD; Carter MC
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1314-1316. PubMed ID: 30149096
[No Abstract] [Full Text] [Related]
29. Omalizumab in the Treatment of Hyper-IgE Syndrome: 2 Case Reports.
Gomes N; Miranda J; Lopes S; Carneiro-Leão L; Torres Costa J; Baudrier T; Azevedo F
J Investig Allergol Clin Immunol; 2020; 30(3):191-192. PubMed ID: 31820738
[No Abstract] [Full Text] [Related]
30. Anaphylaxis after hymenoptera sting: is it venom allergy, a clonal disorder, or both?
Castells MC; Hornick JL; Akin C
J Allergy Clin Immunol Pract; 2015; 3(3):350-5. PubMed ID: 25858055
[TBL] [Abstract][Full Text] [Related]
31. Omalizumab and hypersensitivity reactions.
Shankar T; Petrov AA
Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):19-24. PubMed ID: 23242113
[TBL] [Abstract][Full Text] [Related]
32. The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology.
Mauro M; Incorvaia C; Formigoni C; Elia R; Russello M; Pellegrino D
Panminerva Med; 2012 Dec; 54(4):305-12. PubMed ID: 23123583
[TBL] [Abstract][Full Text] [Related]
33. Clinical aspects of oral immunotherapy for the treatment of allergies.
Yanagida N; Sato S; Ebisawa M
Semin Immunol; 2017 Apr; 30():45-51. PubMed ID: 28780220
[TBL] [Abstract][Full Text] [Related]
34. Anaphylaxis after Elosulfase A infusion: Omalizumab as coadjuvant for enzyme replacement therapy desensitization.
Arroabarren E; Aznal E; Anda M; Sanchez-Valverde F
Pediatr Allergy Immunol; 2019 Jun; 30(4):491-494. PubMed ID: 30817035
[No Abstract] [Full Text] [Related]
35. How omalizumab came to be studied as a therapy for chronic spontaneous/idiopathic urticaria.
Kaplan AP; Joseph K; Saini SS
J Allergy Clin Immunol Pract; 2015; 3(4):648. PubMed ID: 26164583
[No Abstract] [Full Text] [Related]
36. Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate.
Perino E; Freymond N; Devouassoux G; Nicolas JF; Berard F
Ann Allergy Asthma Immunol; 2018 Jun; 120(6):664-666. PubMed ID: 29481891
[No Abstract] [Full Text] [Related]
37. Omalizumab in idiopathic anaphylaxis.
Warrier P; Casale TB
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):257-8. PubMed ID: 19354075
[No Abstract] [Full Text] [Related]
38. Successful treatment of four types of chronic urticaria with anti-IgE omalizumab in the same patient.
Nettis E; Di Leo E; Calogiuri G; Foti C; Macchia L
Ann Allergy Asthma Immunol; 2019 Mar; 122(3):336-337. PubMed ID: 30529714
[No Abstract] [Full Text] [Related]
39. Off-Label Uses of Omalizumab.
El-Qutob D
Clin Rev Allergy Immunol; 2016 Feb; 50(1):84-96. PubMed ID: 26048266
[TBL] [Abstract][Full Text] [Related]
40. Exercise-induced anaphylaxis after consumption of red meat in a patient with IgE antibodies specific for galactose-alpha-1,3-galactose.
Knight ME; Wyatt K; James HC
J Allergy Clin Immunol Pract; 2015; 3(5):801-2. PubMed ID: 26028298
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
